Optimal Predilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis
OPTIMIS
2 other identifiers
interventional
82
1 country
1
Brief Summary
The aim of the study is to investigate if lesion preparation with a ScoreFlex balloon compared to a standard non-compliant balloon improve vascular healing and minimize lumen reduction after implantation of a Magmaris bioresorbable scaffold.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable coronary-artery-disease
Started Dec 2020
Typical duration for not_applicable coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 27, 2020
CompletedFirst Posted
Study publicly available on registry
December 14, 2020
CompletedStudy Start
First participant enrolled
December 14, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedSeptember 13, 2023
September 1, 2023
3.2 years
November 27, 2020
September 12, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Minimal Lumen Area
Minimal Lumen Area
6 months after index percutaneous coronary intervention
Secondary Outcomes (4)
Change in remodeling Index
6 months and 12 months after index percutaneous coronary intervention
Change in Minimal Lumen Area
6 months and 12 months after index percutaneous coronary intervention
Percentage of incomplete scaffold apposition
6 months and 12 months after index percutaneous coronary intervention
Percentage of uncovered struts
6 months and 12 months after index percutaneous coronary intervention
Study Arms (2)
ScoreFlex balloon
ACTIVE COMPARATORPre-dilatation with a ScoreFlex balloon before implantation with a Magmaris bioresorbable scaffold
Standard non-compliant balloon
ACTIVE COMPARATORPre-dilatation with a non-compliant balloon before implantation with a Magmaris bioresorbable scaffold
Interventions
Pre-dilatation with a standard non-compliant balloon
Eligibility Criteria
You may qualify if:
- Patients with stable angina pectoris and non-ST elevation myocardial infarction referred for invasive coronary angiography and percutaneous coronary intervention at Department of Cardiology, Odense University Hospital (Odense, Denmark)
You may not qualify if:
- participation in other randomized clinical trials
- life expectancy \< 1 year
- allergy to aspirin, clopidogrel, ticagrelor or prasugrel
- eGFR \< 30 mL/min
- tortuous and angiographically estimated extremely calcified lesions
- ostial, left main and bifurcation lesions
- lesions in a reference vessel diameter \< 2.0 mm
- hemodynamic instability
- scheduled for coronary artery bypass grafting
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Odense University Hospital
Odense, 5000, Denmark
Related Publications (2)
Hansen KN, Maehara A, Troan J, Noori M, Hougaard M, Ellert-Gregersen J, Veien KT, Junker A, Hansen HS, Lassen JF, Jensen LO. Mechanistic insights into lumen reduction after implantation of a drug-eluting bioresorbable metallic scaffold assessed with serial intracoronary imaging: from the OPTIMIS trial. Coron Artery Dis. 2026 Mar 1;37(2):84-94. doi: 10.1097/MCA.0000000000001561. Epub 2025 Aug 20.
PMID: 40832681DERIVEDHansen KN, Troan J, Maehara A, Noori M, Hougaard M, Ellert-Gregersen J, Veien KT, Junker A, Hansen HS, Lassen JF, Jensen LO. Optimal Predilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis: The OPTIMIS Trial. Circ Cardiovasc Interv. 2025 Jan;18(1):e014665. doi: 10.1161/CIRCINTERVENTIONS.124.014665. Epub 2025 Jan 21.
PMID: 39836741DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Lisette O. Jensen, MD PhD Prof
Odense University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Offline data analysis will be performed without knowing the allocated intervention group.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 27, 2020
First Posted
December 14, 2020
Study Start
December 14, 2020
Primary Completion
March 8, 2024
Study Completion
December 31, 2024
Last Updated
September 13, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share